Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000236700 | SCV000294162 | uncertain significance | not provided | 2022-11-28 | criteria provided, single submitter | clinical testing | Reported in a single individual with CMT and classified as a variant of uncertain signficance by the authors; no information about patient phenotype or segregation was provided (Volodarsky et al., 2021); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32376792) |
Illumina Laboratory Services, |
RCV000292250 | SCV000373811 | uncertain significance | Autosomal recessive distal spinal muscular atrophy 1 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Labcorp Genetics |
RCV000556244 | SCV000642353 | likely benign | Autosomal recessive distal spinal muscular atrophy 1; Charcot-Marie-Tooth disease axonal type 2S | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000236700 | SCV001144479 | likely benign | not provided | 2019-02-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000236700 | SCV001148364 | uncertain significance | not provided | 2022-02-01 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173347 | SCV001336435 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002436064 | SCV002748456 | uncertain significance | Inborn genetic diseases | 2023-10-05 | criteria provided, single submitter | clinical testing | The c.2837G>A (p.R946Q) alteration is located in exon 15 (coding exon 15) of the IGHMBP2 gene. This alteration results from a G to A substitution at nucleotide position 2837, causing the arginine (R) at amino acid position 946 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV000236700 | SCV003813316 | uncertain significance | not provided | 2020-03-06 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000236700 | SCV004226199 | uncertain significance | not provided | 2022-10-31 | criteria provided, single submitter | clinical testing | BP4 |